Rare diseases
Investigational molecules
Locations
Back to Czechia17 clinical trials in Horni Predmesti, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
CzechiaStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
CzechiaStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
CzechiaEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
CzechiaKAI-9531 in Adults With Obesity or Overweight and Diabetes
CzechiaStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
CzechiaA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
CzechiaA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
CzechiaLong-Term Safety Study of Plozasiran for Adults with High Triglycerides
CzechiaStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
CzechiaStudy to Evaluate Plozasiran for Adults with High Triglycerides
CzechiaStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on cardiovascular disease prevention and treatment, with studies evaluating new therapeutic approaches for reducing major cardiovascular events.
Advanced trials exploring novel treatments for atherosclerotic cardiovascular disease prevention.
Comprehensive studies addressing various forms of lipid disorders, including trials for hypertriglyceridemia and hypercholesterolemia management.
Multiple trials evaluating new compounds for improving lipid profiles and patient outcomes.
Specialized research focusing on atrial fibrillation treatments, including comparative studies of novel anticoagulation approaches.
Groundbreaking studies examining new therapeutic options for patients with irregular heart rhythms.
Clinical investigations targeting heart failure treatment through combination therapy approaches and innovative drug development.
Evaluating novel therapeutic combinations to enhance outcomes in heart failure patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
